Latest Breaking News On - Joe burlison - Page 1 : vimarsana.com

Poster Includes Preclinical Data on Novel Direct Pan-RAS Inhibitors CARLSBAD, Calif., April 10, 2024 (GLOBE NEWSWIRE) Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN) today announces a poster presentation on its preclinical Novel Direct Pan-RAS Inhibitors was presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 held April 5 – 10 in San Diego, California. “We continue to see cancers developing resistance to current clinical agents that tar

United statesUniversity of louisvilleSan diegoGeoff clarkJohn trentMichael poirierMike saboJoe burlisonRob monsenHoward donningerRachel ferrilTariq arshadGeoffreyj clarkAmerican association for cancer researchQualigen therapeutics incPoster includes